Hemopure hemoglobin glutamer: Phase II completed enrollment

BPUR completed enrollment of 46 CAD patients in a double-blind, placebo-controlled, European Phase II trial. Patients will receive 15 or 30g IV Hemopure or placebo before undergoing elective coronary ...